Northwestern Medicine continues to help advance the understanding of the COVID-19 pandemic and its widespread impact, from investigating antibody protection against COVID-19 reinfection to elevating women in academic research to highlighting racial and ethnic disparities in COVID-19 hospital mortality in Illinois.
Of the estimated five million patients in the U.S. diagnosed with heart failure annually, nearly half will have heart failure with preserved ejection fraction (HFpEF) and at the forefront of HFpEF research are Feinberg investigators.
A new publication outlines the structure-function relationships between the first spherical nucleic acid vaccine developed to protect against viral infections, including COVID-19.
Black women with early hormone receptor-positive breast cancer experienced shorter relapse-free intervals and overall survival compared with white women, according to findings published in JAMA Oncology.
Northwestern Medicine scientists discovered functional links between dozens of potassium channel gene variants and neonatal epilepsy.
A genetic analysis indicates eosinophilic colitis is distinct from other eosinophilic gastrointestinal diseases and inflammatory bowel disease, according to a recent study.
Idiopathic dilated cardiomyopathy (DCM) was found to have a familial etiology in 30 percent of individuals diagnosed with DCM, and the overall risk for a family member of developing DCM was nearly 20 percent by the age of 80.
Pregnant and postpartum individuals infected with SARS-CoV-2 during pregnancy have an increased risk of maternal mortality or morbidity from obstetric complications, according to a recent study.
Recent advances from Northwestern investigators have powered a new, deeper understanding of Parkinson’s disease that could pave the way to a disease-modifying treatment.
A new study shines a spotlight on an important but often overlooked matter of the heart — optimizing cardiovascular health before getting pregnant.
Notifications